These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27180266)

  • 21. Small Cell Carcinoma of the Urinary Bladder: A Retrospective, Multicenter Rare Cancer Network Study of 107 Patients.
    Pasquier D; Barney B; Sundar S; Poortmans P; Villa S; Nasrallah H; Boujelbene N; Ghadjar P; Lassen-Ramshad Y; Senkus E; Oar A; Roelandts M; Amichetti M; Vees H; Zilli T; Ozsahin M
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):904-10. PubMed ID: 26104942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a.
    May M; Bastian PJ; Brookman-May S; Fritsche HM; Tilki D; Otto W; Bolenz C; Gilfrich C; Trojan L; Herrmann E; Moritz R; Tiemann A; Müller SC; Ellinger J; Buchner A; Stief CG; Wieland WF; Höfner T; Hohenfellner M; Haferkamp A; Roigas J; Zacharias M; Nuhn P; Burger M
    Urol Oncol; 2013 Oct; 31(7):1141-7. PubMed ID: 22056404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive and prognostic significance of neuron-specific enolase (NSE) in non-small cell lung cancer.
    Tiseo M; Ardizzoni A; Cafferata MA; Loprevite M; Chiaramondia M; Filiberti R; Marroni P; Grossi F; Paganuzzi M
    Anticancer Res; 2008; 28(1B):507-13. PubMed ID: 18383893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prognostic significance of circulating neuroendocrine markers chromogranin a, pro-gastrin-releasing peptide and neuron-specific enolase in patients with advanced non-small-cell lung cancer.
    Nisman B; Heching N; Biran H; Barak V; Peretz T
    Tumour Biol; 2006; 27(1):8-16. PubMed ID: 16340245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The changes in serum neuron-specific enolase in patients with small cell lung cancer].
    Taitou H; Sakurai M; Tamura T; Sasaki Y; Eguchi K; Shinkai T; Ookura H; Saijo N
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3046-9. PubMed ID: 2823722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Small cell carcinoma of urinary bladder is differentiated from urothelial carcinoma by chromogranin expression, absence of CD44 variant 6 expression, a unique pattern of cytokeratin expression, and more intense gamma-enolase expression.
    Iczkowski KA; Shanks JH; Allsbrook WC; Lopez-Beltran A; Pantazis CG; Collins TR; Wetherington RW; Bostwick DG
    Histopathology; 1999 Aug; 35(2):150-6. PubMed ID: 10460660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary small cell carcinoma of the urinary bladder. Report of a case with immunohistochemical analyses.
    Höbarth K; Wrba F; Hofbauer J
    Urol Int; 1992; 48(1):95-8. PubMed ID: 1317981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum neuron specific enolase level as a prognostic factor in non-small cell lung cancer.
    Andoh M; Gemma A; Takenaka K; Hisakatsu S; Yamada K; Usuki J; Hasegawa K; Sakonji M; Kudoh S; Tsuboi E
    Intern Med; 1994 May; 33(5):271-6. PubMed ID: 7949629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ras association domain family 1A: a promising prognostic marker in recurrent nonmuscle invasive bladder cancer.
    Kim JS; Chae Y; Ha YS; Kim IY; Byun SS; Yun SJ; Kim WJ
    Clin Genitourin Cancer; 2012 Jun; 10(2):114-20. PubMed ID: 22382007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High neuron specific enolase levels in bronchoalveolar lavage fluid of patients with lung carcinoma: diagnostic value, relation to serum neuron specific enolase, and staging.
    Dowlati A; Bury T; Corhay JL; Weber T; Mendes P; Radermecker M
    Cancer; 1996 May; 77(10):2039-43. PubMed ID: 8640667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Occurrence of neuron specific enolase in tumour tissue and serum in small cell lung cancer.
    Jørgensen LG; Hirsch FR; Skov BG; Osterlind K; Cooper EH; Larsson LI
    Br J Cancer; 1991 Jan; 63(1):151-3. PubMed ID: 1703432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination of CK20 and Ki-67 immunostaining analysis predicts recurrence, progression, and cancer-specific survival in pT1 urothelial bladder cancer.
    Bertz S; Otto W; Denzinger S; Wieland WF; Burger M; Stöhr R; Link S; Hofstädter F; Hartmann A
    Eur Urol; 2014 Jan; 65(1):218-26. PubMed ID: 22633802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of tumor markers, NSE, CA125 and SCC, in operable NSCLC Patients.
    Yu D; Du K; Liu T; Chen G
    Int J Mol Sci; 2013 May; 14(6):11145-56. PubMed ID: 23712355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genitourinary small cell carcinoma: determination of clinical and therapeutic factors associated with survival.
    Mackey JR; Au HJ; Hugh J; Venner P
    J Urol; 1998 May; 159(5):1624-9. PubMed ID: 9554367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain metastases at the time of presentation of non-small cell lung cancer: a multi-centric AERIO analysis of prognostic factors.
    Jacot W; Quantin X; Boher JM; Andre F; Moreau L; Gainet M; Depierre A; Quoix E; Chevalier TL; Pujol JL;
    Br J Cancer; 2001 Apr; 84(7):903-9. PubMed ID: 11286469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical review - small cell carcinoma of the bladder.
    Church DN; Bahl A
    Cancer Treat Rev; 2006 Dec; 32(8):588-93. PubMed ID: 17008012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Neuron-specific enolase (NSE) in the surveillance of small cell cancers. An evaluation of the prognostic information using Markov's model].
    Pujol JL; Boher JM; Grenier J; Quantin X; Saffont L; Daurès JP
    Rev Mal Respir; 1998 Sep; 15(4):519-25. PubMed ID: 9805763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical management of small-cell carcinoma of the urinary tract: a 10-year single-center's experience.
    Carranza OE; Castañón E; Abella LE; Zudaire ME; Castillo A; Arévalo E; Fusco JP; Zudaire JJ; Carías R; Cambeiro M; Martínez-Monge R; Gil-Bazo I
    Clin Genitourin Cancer; 2013 Jun; 11(2):168-74. PubMed ID: 23146567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C-reactive protein level predicts prognosis in patients with muscle-invasive bladder cancer treated with chemoradiotherapy.
    Yoshida S; Saito K; Koga F; Yokoyama M; Kageyama Y; Masuda H; Kobayashi T; Kawakami S; Kihara K
    BJU Int; 2008 Apr; 101(8):978-81. PubMed ID: 18190628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.